clinical trial · NCT03972111
A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox
SmallpoxTPOXX 200Mg Capsule
brief summary
Phase 4, Observational Field Study in Patients Treated With TPOXX for Smallpox Disease
started
Jan 1, 2020
primary completion
Sep 30, 2024
completion
Sep 30, 2024
last updated
Sep 10, 2026
detailed description
Phase 4, Observational Field Study to evaluate safety and clinical benefit of TPOXX (tecovirimat) in patients treated with TPOXX following exposure to variola virus and a clinical diagnosis of smallpox disease.
official title
A Phase 4, Observational Field Study to Evaluate the Safety and Clinical Benefit of TPOXX (Tecovirimat)-Treated Patients Following Exposure to Variola Virus and Clinical Diagnosis of Smallpox Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol